| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1423-0410.2004.00533.X |
| P8608 | Fatcat ID | release_gpxou54klfgldhaqtdta6bqcdm |
| P698 | PubMed publication ID | 15260820 |
| P5875 | ResearchGate publication ID | 8448413 |
| P2093 | author name string | J Klausner | |
| Y Kluger | |||
| A Mayo | |||
| D Pauzner | |||
| M Misgav | |||
| O Ben-Tal | |||
| R Geenberg | |||
| P2860 | cites work | High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. | Q33338284 |
| On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation | Q33342552 | ||
| To general haemostasis--the evidence-based route | Q33344110 | ||
| Ongoing NovoSeven trials | Q33344984 | ||
| Clinical use of recombinant FVIIa (rFVIIa). | Q33584641 | ||
| The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. | Q34090261 | ||
| Management of massive blood loss: a template guideline | Q34096593 | ||
| Major postpartum haemorrhage | Q34438360 | ||
| Potential role for rFVIIa in transfusion medicine | Q34564930 | ||
| The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients | Q34817997 | ||
| Updates in the management of severe coagulopathy in trauma patients | Q34982424 | ||
| Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients | Q35138036 | ||
| Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation | Q44201546 | ||
| Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program | Q45857020 | ||
| Treatment of traumatic bleeding with recombinant factor VIIa. | Q55033461 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 34-40 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Vox Sanguinis | Q15708866 |
| P1476 | title | Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding | |
| P478 | volume | 87 |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q35788608 | Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas |
| Q35202023 | Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system |
| Q37691716 | Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs |
| Q36284640 | Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma |
| Q33633854 | Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use. |
| Q50746970 | Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome. |
| Q35629970 | Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials |
| Q83193555 | Recombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system |
| Q31146886 | Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data |
| Q36077574 | Recombinant factor VIIa in the treatment of non-hemophiliac bleeding |
| Q34135771 | Recombinant factor VIIa use in patients presenting with intracranial hemorrhage |
| Q36412132 | Recombinant factor VIIa: a review on its clinical use. |
| Q45207216 | Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder |
| Q50547561 | The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel. |
| Q36150578 | The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients |
| Q50664916 | Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. |
Search more.